• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

过继输注 DNT 细胞可诱导心脏移植物长期存活,并增加受体 CD4(+)Foxp3(+)Treg 细胞的积聚。

Adoptive transfer of DNT cells induces long-term cardiac allograft survival and augments recipient CD4(+)Foxp3(+) Treg cell accumulation.

机构信息

The Multi-Organ Transplant Program, London Health Sciences Centre, London, Ontario, Canada.

出版信息

Transpl Immunol. 2011 Jan 15;24(2):119-26. doi: 10.1016/j.trim.2010.11.003. Epub 2010 Nov 9.

DOI:10.1016/j.trim.2010.11.003
PMID:21073952
Abstract

Regulatory T (Treg) cells play an important role in the regulation of immune responses but whether Treg will induce tolerance in transplant recipients in the clinic remains unknown. Our previous studies have shown that TCRαβ(+)CD3(+)CD4⁻CD8⁻NK1.1⁻ (double negative, DN) T cells suppress T cell responses and prolong allograft survival in a single locus MHC-mismatched mouse model. In this study, we investigated the role of DNT cells in a more robust, fully MHC-mismatched BALB/c to C57BL/6 transplantation model, which may be more clinically relevant. Adoptive transfer of DNT cells in combination with short-term rapamycin treatment (days 1-9) induced long-term heart allograft survival (101±31 vs. 39±13 days rapamycin alone, p<0.01). Furthermore adoptive transfer DNT cells augmented CD4+Foxp3+ Treg cells accumulation in transplant recipients while depletion of CD4(+) Treg cells by anti-CD25 inhibited the effect of DNT cells on long-term graft survival (48±12 days vs. 101±31 days, p<0.001). In conclusion, DNT cells combined with short-term immunosuppression can prolong allograft survival, which may be through the accumulation of CD4(+)Foxp3(+) Treg cells in the recipient. Our result suggests that allograft tolerance may require the co-existence of different type Treg cell phenotypes which are affected by current immunosuppression.

摘要

调节性 T(Treg)细胞在调节免疫反应中发挥重要作用,但 Treg 是否会在临床上诱导移植受者的耐受尚不清楚。我们之前的研究表明,TCRαβ(+)CD3(+)CD4(-)CD8(-)NK1.1(-)(双阴性,DN)T 细胞可抑制 T 细胞反应并延长单基因座 MHC 错配小鼠模型中的同种异体移植物存活时间。在这项研究中,我们在更强大的、完全 MHC 错配的 BALB/c 到 C57BL/6 移植模型中研究了 DNT 细胞的作用,这可能更具临床相关性。在短期雷帕霉素治疗(第 1-9 天)的同时过继转移 DNT 细胞可诱导长期心脏同种异体移植物存活(雷帕霉素单独使用 101±31 天 vs. 39±13 天,p<0.01)。此外,过继转移 DNT 细胞可增加移植受者中 CD4+Foxp3+Treg 细胞的积累,而通过抗 CD25 耗竭 CD4(+)Treg 细胞可抑制 DNT 细胞对长期移植物存活的影响(48±12 天 vs. 101±31 天,p<0.001)。总之,DNT 细胞联合短期免疫抑制可延长同种异体移植物的存活时间,这可能是通过受体中 CD4(+)Foxp3(+)Treg 细胞的积累实现的。我们的结果表明,同种异体耐受可能需要不同类型 Treg 细胞表型的共存,而这受当前免疫抑制的影响。

相似文献

1
Adoptive transfer of DNT cells induces long-term cardiac allograft survival and augments recipient CD4(+)Foxp3(+) Treg cell accumulation.过继输注 DNT 细胞可诱导心脏移植物长期存活,并增加受体 CD4(+)Foxp3(+)Treg 细胞的积聚。
Transpl Immunol. 2011 Jan 15;24(2):119-26. doi: 10.1016/j.trim.2010.11.003. Epub 2010 Nov 9.
2
Increased CD4+CD25+Foxp3+ regulatory T cells in tolerance induced by portal venous injection.门静脉注射诱导的耐受中CD4+CD25+Foxp3+调节性T细胞增加。
Surgery. 2009 Jun;145(6):663-74. doi: 10.1016/j.surg.2009.01.016. Epub 2009 Apr 19.
3
The role of Foxp3+ regulatory T cells in liver transplant tolerance.Foxp3+调节性T细胞在肝移植耐受中的作用。
Transplant Proc. 2006 Dec;38(10):3205-6. doi: 10.1016/j.transproceed.2006.10.093.
4
Combined therapy of CD4(+)CD25(+) regulatory T cells with low-dose sirolimus, but not calcineurin inhibitors, preserves suppressive function of regulatory T cells and prolongs allograft survival in mice.CD4(+)CD25(+)调节性 T 细胞联合小剂量西罗莫司而非钙调磷酸酶抑制剂治疗可保持调节性 T 细胞的抑制功能,并延长小鼠同种异体移植物的存活时间。
Int Immunopharmacol. 2009 May;9(5):553-63. doi: 10.1016/j.intimp.2009.01.033. Epub 2009 Feb 8.
5
Adoptive transfer of double negative T regulatory cells induces B-cell death in vivo and alters rejection pattern of rat-to-mouse heart transplantation.双阴性调节性T细胞的过继转移在体内诱导B细胞死亡,并改变大鼠到小鼠心脏移植的排斥模式。
Xenotransplantation. 2008 Feb;15(1):56-63. doi: 10.1111/j.1399-3089.2008.00444.x.
6
Short-term anti-CD25 monoclonal antibody treatment and neogenetic CD4(+)CD25(high) regulatory T cells in kidney transplantation.肾移植中的短期抗CD25单克隆抗体治疗与新生CD4(+)CD25(高表达)调节性T细胞
Transpl Immunol. 2008 Apr;19(1):69-73. doi: 10.1016/j.trim.2008.01.005. Epub 2008 Feb 22.
7
Adoptive transfusion of ex vivo donor alloantigen-stimulated CD4(+)CD25(+) regulatory T cells ameliorates rejection of DA-to-Lewis rat liver transplantation.体外供体同种异体抗原刺激的CD4(+)CD25(+)调节性T细胞的过继性输血可改善DA到Lewis大鼠肝移植的排斥反应。
Surgery. 2007 Jul;142(1):67-73. doi: 10.1016/j.surg.2007.02.014.
8
The effect of immunosuppressive drug rapamycin on regulatory CD4+CD25+Foxp3+T cells in mice.免疫抑制药物雷帕霉素对小鼠调节性CD4+CD25+Foxp3+T细胞的影响。
Transpl Immunol. 2007 Apr;17(3):153-61. doi: 10.1016/j.trim.2007.01.002. Epub 2007 Jan 24.
9
Adoptive transfer of transplantation tolerance mediated by CD4+CD25+ and CD8+CD28- regulatory T cells induced by anti-donor-specific T-cell vaccination.通过抗供体特异性T细胞疫苗诱导的CD4 + CD25 +和CD8 + CD28 -调节性T细胞介导的移植耐受的过继转移。
Transplant Proc. 2008 Jun;40(5):1612-7. doi: 10.1016/j.transproceed.2008.02.079.
10
Bilirubin promotes de novo generation of T regulatory cells.胆红素促进 T 调节细胞的从头生成。
Cell Transplant. 2010;19(4):443-51. doi: 10.3727/096368909X484680. Epub 2009 Dec 18.

引用本文的文献

1
Double-negative T cells in combination with ursodeoxycholic acid ameliorates immune-mediated cholangitis in mice.双阴性T细胞与熊去氧胆酸联合使用可改善小鼠免疫介导的胆管炎。
BMC Med. 2025 Apr 7;23(1):209. doi: 10.1186/s12916-025-04043-9.
2
Case report: Effectiveness of sirolimus in a FAS mutation leading to autoimmune lymphoproliferative syndrome-FAS and elevated DNT/Treg ratio.病例报告:西罗莫司对导致自身免疫性淋巴增殖综合征的FAS突变(FAS)及升高的双阴性T细胞/调节性T细胞比例的有效性。
Front Pediatr. 2022 Jul 28;10:868193. doi: 10.3389/fped.2022.868193. eCollection 2022.
3
Double Negative T Regulatory Cells: An Emerging Paradigm Shift in Reproductive Immune Tolerance?
双阴性调节性 T 细胞:生殖免疫耐受中的新兴范式转变?
Front Immunol. 2022 Jul 1;13:886645. doi: 10.3389/fimmu.2022.886645. eCollection 2022.
4
TCRαβ+ CD4-/CD8- "double negative" T cells in health and disease-implications for the kidney.健康和疾病中的 TCRαβ+ CD4-/CD8-“双阴性”T 细胞——对肾脏的影响。
Kidney Int. 2022 Jul;102(1):25-37. doi: 10.1016/j.kint.2022.02.035. Epub 2022 Apr 9.
5
Current Status of Gene Engineering Cell Therapeutics.基因工程细胞治疗药物的现状。
Front Immunol. 2018 Feb 5;9:153. doi: 10.3389/fimmu.2018.00153. eCollection 2018.
6
T regulatory cell mediated immunotherapy for solid organ transplantation: A clinical perspective.调节性T细胞介导的实体器官移植免疫治疗:临床视角
Mol Med. 2017 Feb;22:892-904. doi: 10.2119/molmed.2016.00050. Epub 2016 Nov 22.
7
Advances on Non-CD4 + Foxp3+ T Regulatory Cells: CD8+, Type 1, and Double Negative T Regulatory Cells in Organ Transplantation.非CD4 + Foxp3 + 调节性T细胞的研究进展:器官移植中的CD8 + 、1型及双阴性调节性T细胞
Transplantation. 2015 Aug;99(8):1553-9. doi: 10.1097/TP.0000000000000813.
8
Transplantation tolerance and its outcome during infections and inflammation.感染和炎症期间的移植耐受及其结果。
Immunol Rev. 2014 Mar;258(1):80-101. doi: 10.1111/imr.12147.
9
CD4(+)CD25(-)Nrp1(+) T cells synergize with rapamycin to prevent murine cardiac allorejection in immunocompetent recipients.CD4(+)CD25(-)Nrp1(+) T 细胞与雷帕霉素协同作用,可预防免疫功能正常受者的小鼠同种异体心脏排斥反应。
PLoS One. 2013;8(4):e61151. doi: 10.1371/journal.pone.0061151. Epub 2013 Apr 5.
10
Immunoregulatory CD4(-)CD8(-) T cells as a potential therapeutic tool for transplantation, autoimmunity, and cancer.免疫调节性 CD4(-)CD8(-)T 细胞作为移植、自身免疫和癌症的潜在治疗工具。
Front Immunol. 2013 Jan 24;4:6. doi: 10.3389/fimmu.2013.00006. eCollection 2013.